Samuel Barnes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Samuel Barnes has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
Axel Montagne
Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, USA
7 shared publications- Berislav V. Zlokovic
University of Southern California
7 shared publications - Russell E. Jacobs
Zilkha Neurogenetic Institute, University of Southern California Keck School of Medicine
6 shared publications E. Mark Haacke
Loma Linda University Medical Center
5 shared publications- Grant McAuley
Department of Radiation Medicine, Loma Linda University, Loma Linda, CA, USA
5 shared publications Abhay P. Sagare
Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, USA
4 shared publications
Latest Publications
- Open Access
- 13 August 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 94 (6) , 2732-2744
Automatic detection of arterial input function for brain DCE‐MRI in multi‐site cohorts
Purpose: Arterial input function (AIF) extraction is a crucial step in quantitative pharmacokinetic modeling of DCE‐MRI. This work proposes a robust deep learning model that can precisely extract an AIF from DCE‐MRI images.Methods: A diverse dataset of human brain DCE‐MRI images from 289 participants, totaling 384 scans, from five different institutions with extracted gadolinium‐based contrast agent curves from large penetrating arteries, and with most data collected for blood–brain barrier (BBB) permeability measurement, was retrospectively analyzed. A 3D UNet model was implemented and trained on manually drawn AIF regions. The testing cohort was compared using proposed AIF quality metric AIFitness and Ktrans values from a standard DCE pipeline. This UNet was then applied to a separate dataset of 326 participants with a total of 421 DCE‐MRI images with analyzed AIF quality and Ktrans values.Results: The resulting 3D UNet model achieved an average AIFitness score of 93.9 compared to 99.7 for manually selected AIFs, and white matter Ktrans values were 0.45/min × 10−3 and 0.45/min × 10−3, respectively. The intraclass correlation between automated and manual Ktrans values was 0.89. The separate replication dataset yielded an AIFitness score of 97.0 and white matter Ktrans of 0.44/min × 10−3.Conclusion: Findings suggest a 3D UNet model with additional convolutional neural network kernels and a modified Huber loss function achieves superior performance for identifying AIF curves from DCE‐MRI in a diverse multi‐center cohort. AIFitness scores and DCE‐MRI‐derived metrics, such as Ktrans maps, showed no significant differences in gray and white matter between manually drawn and automated AIFs.
- 13 August 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 94 (6) , 2732-2744
Open AccessAutomatic detection of arterial input function for brain DCE‐MRI in multi‐site cohorts
Purpose: Arterial input function (AIF) extraction is a crucial step in quantitative pharmacokinetic modeling of DCE‐MRI. This work proposes a robust deep learning model that can precisely extract an AIF from DCE‐MRI images.Methods: A diverse dataset of human brain DCE‐MRI images from 289 participants, totaling 384 scans, from five different institutions with extracted gadolinium‐based contrast agent curves from large penetrating arteries, and with most data collected for blood–brain barrier (BBB) permeability measurement, was retrospectively analyzed. A 3D UNet model was implemented and trained on manually drawn AIF regions. The testing cohort was compared using proposed AIF quality metric AIFitness and Ktrans values from a standard DCE pipeline. This UNet was then applied to a separate dataset of 326 participants with a total of 421 DCE‐MRI images with analyzed AIF quality and Ktrans values.Results: The resulting 3D UNet model achieved an average AIFitness score of 93.9 compared to 99.7 for manually selected AIFs, and white matter Ktrans values were 0.45/min × 10−3 and 0.45/min × 10−3, respectively. The intraclass correlation between automated and manual Ktrans values was 0.89. The separate replication dataset yielded an AIFitness score of 97.0 and white matter Ktrans of 0.44/min × 10−3.Conclusion: Findings suggest a 3D UNet model with additional convolutional neural network kernels and a modified Huber loss function achieves superior performance for identifying AIF curves from DCE‐MRI in a diverse multi‐center cohort. AIFitness scores and DCE‐MRI‐derived metrics, such as Ktrans maps, showed no significant differences in gray and white matter between manually drawn and automated AIFs.
- Open Access
- 4 July 2024
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 112, 82-88
Comparison and precision of visceral adipose tissue measurement techniques in a multisite longitudinal study using MRI
- 4 July 2024
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 112, 82-88
Open AccessComparison and precision of visceral adipose tissue measurement techniques in a multisite longitudinal study using MRI
- RetractionOpen Access
- 5 April 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (4) , 1215
Retraction Note: Pericyte degeneration causes white matter dysfunction in the mouse central nervous system
- 5 April 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (4) , 1215
RetractionOpen AccessRetraction Note: Pericyte degeneration causes white matter dysfunction in the mouse central nervous system
- Open Access
- 14 February 2024
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 144 (4) , 1503-1509
Clinical compatibility of magnetic resonance imaging with magnetic intramedullary nails: a feasibility study
Introduction: The use of magnetic resonance imaging (MRI) with a magnetic intramedullary lengthening nail in place is contraindicated per the manufacturer due to the concern of implant activation and migration. A prior in vitro study did not confirm these complications only noting that a 3.0 T MRI weakened the internal magnet. Therefore, a retrospective analysis of patients who underwent an MRI with a magnetic nail in place was performed to determine if any adverse effects occurred in the clinical setting. Materials and methods: A retrospective review of all patients who underwent an MRI with a magnetic lengthening nail in place was performed. The time spent being imaged in the MRI, number of times the patient entered the MRI suite, and the images obtained were recorded. Radiographs were performed before and after the MRI to determine if any hardware complications occurred. The patients were monitored for any adverse symptoms while they were in the suite. Results: A total of 12 patients with 13 nails were identified. Two patients underwent imaging with a 3.0 T MRI while the remaining 10 underwent imaging with a 1.5 T MRI. Each patient entered the MRI suite 2.1 times and spent an average of 84.7 min being imaged in the MRI (range 21–494). No patients noted any adverse symptoms related to the nail while in the suite and no hardware complications were identified. Conclusion: MRI appears to be safe with a magnetic nail in place and did not result in any complications. Given the manufacturer’s recommendations, informed consent should be obtained prior to an MRI being performed and a 3.0 T MRI should be avoided when possible if further activation of the nail is required.
- 14 February 2024
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 144 (4) , 1503-1509
Open AccessClinical compatibility of magnetic resonance imaging with magnetic intramedullary nails: a feasibility study
Introduction: The use of magnetic resonance imaging (MRI) with a magnetic intramedullary lengthening nail in place is contraindicated per the manufacturer due to the concern of implant activation and migration. A prior in vitro study did not confirm these complications only noting that a 3.0 T MRI weakened the internal magnet. Therefore, a retrospective analysis of patients who underwent an MRI with a magnetic nail in place was performed to determine if any adverse effects occurred in the clinical setting. Materials and methods: A retrospective review of all patients who underwent an MRI with a magnetic lengthening nail in place was performed. The time spent being imaged in the MRI, number of times the patient entered the MRI suite, and the images obtained were recorded. Radiographs were performed before and after the MRI to determine if any hardware complications occurred. The patients were monitored for any adverse symptoms while they were in the suite. Results: A total of 12 patients with 13 nails were identified. Two patients underwent imaging with a 3.0 T MRI while the remaining 10 underwent imaging with a 1.5 T MRI. Each patient entered the MRI suite 2.1 times and spent an average of 84.7 min being imaged in the MRI (range 21–494). No patients noted any adverse symptoms related to the nail while in the suite and no hardware complications were identified. Conclusion: MRI appears to be safe with a magnetic nail in place and did not result in any complications. Given the manufacturer’s recommendations, informed consent should be obtained prior to an MRI being performed and a 3.0 T MRI should be avoided when possible if further activation of the nail is required.
- Open Access
- 2 September 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1278
Omega-3 Fatty Acids, Cognition, and Brain Volume in Older Adults
The elderly population is growing at increased rates and is expected to double in size by 2050 in the United States and worldwide. The consumption of healthy foods and enriched diets have been associated with improved cognition and brain health. The key nutrients common to many healthy foods and diets are the omega-3 polyunsaturated fatty acids (omega-3 FAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). We explored whether omega-3 FA levels are associated with brain volume and cognition. Forty healthy, cognitively normal, Seventh-day Adventist older adults (mean age 76.3 years at MRI scan, 22 females) completed neurocognitive testing, a blood draw, and structural neuroimaging from 2016 to 2018. EPA and an overall omega-3 index were associated with individual measures of delayed recall (RAVLT-DR) and processing speed (Stroop Color) as well as entorhinal cortex thickness. EPA, DHA, and the omega-3 index were significantly correlated with the total white matter volume. The entorhinal cortex, frontal pole, and total white matter were associated with higher scores on delayed memory recall. This exploratory study found that among healthy, cognitively older adults, increased levels of omega-3 FAs are associated with better memory, processing speed, and structural brain measures.
- 2 September 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1278
Open AccessOmega-3 Fatty Acids, Cognition, and Brain Volume in Older Adults
The elderly population is growing at increased rates and is expected to double in size by 2050 in the United States and worldwide. The consumption of healthy foods and enriched diets have been associated with improved cognition and brain health. The key nutrients common to many healthy foods and diets are the omega-3 polyunsaturated fatty acids (omega-3 FAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). We explored whether omega-3 FA levels are associated with brain volume and cognition. Forty healthy, cognitively normal, Seventh-day Adventist older adults (mean age 76.3 years at MRI scan, 22 females) completed neurocognitive testing, a blood draw, and structural neuroimaging from 2016 to 2018. EPA and an overall omega-3 index were associated with individual measures of delayed recall (RAVLT-DR) and processing speed (Stroop Color) as well as entorhinal cortex thickness. EPA, DHA, and the omega-3 index were significantly correlated with the total white matter volume. The entorhinal cortex, frontal pole, and total white matter were associated with higher scores on delayed memory recall. This exploratory study found that among healthy, cognitively older adults, increased levels of omega-3 FAs are associated with better memory, processing speed, and structural brain measures.
- Open Access
- 5 July 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (14) , e025657
Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial
Background: Excess visceral adiposity is associated with increased risk of cardiometabolic disorders. Short‐term well‐controlled clinical trials suggest that regular avocado consumption favorably affects body weight, visceral adiposity, and satiety. Methods and Results: The HAT Trial (Habitual Diet and Avocado Trial) was a multicenter, randomized, controlled parallel‐arm trial designed to test whether consuming 1 large avocado per day for 6 months in a diverse group of free‐living individuals (N=1008) with an elevated waist circumference compared with a habitual diet would decrease visceral adiposity as measured by magnetic resonance imaging. Secondary and additional end points related to risk factors associated with cardiometabolic disorders were assessed. The primary outcome, change in visceral adipose tissue volume during the intervention period, was not significantly different between the Avocado Supplemented and Habitual Diet Groups (estimated mean difference (0.017 L [−0.024 L, 0.058 L], P =0.405). No significant group differences were observed for the secondary outcomes of hepatic fat fraction, hsCRP (high‐sensitivity C‐reactive protein), and components of the metabolic syndrome. Of the additional outcome measures, modest but nominally significant reductions in total and low‐density lipoprotein cholesterol were observed in the Avocado Supplemented compared with the Habitual Diet Group. Changes in the other additional and post hoc measures (body weight, body mass index, insulin, very low‐density lipoprotein concentrations, and total cholesterol:high‐density lipoprotein cholesterol ratio) were similar between the 2 groups. Conclusions: Addition of 1 avocado per day to the habitual diet for 6 months in free‐living individuals with elevated waist circumference did not reduce visceral adipose tissue volume and had minimal effect on risk factors associated with cardiometabolic disorders. Registration: URL: https://clinicaltrials.gov ; Unique identifier: NCT03528031.
- 5 July 2022
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (14) , e025657
Open AccessEffect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial
Background: Excess visceral adiposity is associated with increased risk of cardiometabolic disorders. Short‐term well‐controlled clinical trials suggest that regular avocado consumption favorably affects body weight, visceral adiposity, and satiety. Methods and Results: The HAT Trial (Habitual Diet and Avocado Trial) was a multicenter, randomized, controlled parallel‐arm trial designed to test whether consuming 1 large avocado per day for 6 months in a diverse group of free‐living individuals (N=1008) with an elevated waist circumference compared with a habitual diet would decrease visceral adiposity as measured by magnetic resonance imaging. Secondary and additional end points related to risk factors associated with cardiometabolic disorders were assessed. The primary outcome, change in visceral adipose tissue volume during the intervention period, was not significantly different between the Avocado Supplemented and Habitual Diet Groups (estimated mean difference (0.017 L [−0.024 L, 0.058 L], P =0.405). No significant group differences were observed for the secondary outcomes of hepatic fat fraction, hsCRP (high‐sensitivity C‐reactive protein), and components of the metabolic syndrome. Of the additional outcome measures, modest but nominally significant reductions in total and low‐density lipoprotein cholesterol were observed in the Avocado Supplemented compared with the Habitual Diet Group. Changes in the other additional and post hoc measures (body weight, body mass index, insulin, very low‐density lipoprotein concentrations, and total cholesterol:high‐density lipoprotein cholesterol ratio) were similar between the 2 groups. Conclusions: Addition of 1 avocado per day to the habitual diet for 6 months in free‐living individuals with elevated waist circumference did not reduce visceral adipose tissue volume and had minimal effect on risk factors associated with cardiometabolic disorders. Registration: URL: https://clinicaltrials.gov ; Unique identifier: NCT03528031.
- 25 April 2022
- Published by Springer Nature in GeroScience
- Vol. 44 (3) , 1339-1351
Imaging subtle leaks in the blood–brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions
Recent studies using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with gadolinium-based contrast agents (GBCA) have demonstrated subtle blood–brain barrier (BBB) leaks in the human brain during normal aging, in individuals with age-related cognitive dysfunction, genetic risk for Alzheimer’s disease (AD), mild cognitive impairment, early AD, cerebral small vessel disease (SVD), and other neurodegenerative disorders. In these neurological conditions, the BBB leaks, quantified by the unidirectional BBB GBCA tracer’s constant Ktrans maps, are typically orders of magnitude lower than in brain tumors, after stroke and/or during relapsing episodes of multiple sclerosis. This puts extra challenges for the DCE-MRI technique by pushing calculations towards its lower limits of detectability. In addition, presently, there are no standardized multivendor protocols or evidence of repeatability and reproducibility. Nevertheless, subtle BBB leaks may critically contribute to the pathophysiology of cognitive impairment and dementia associated with AD or SVD, and therefore, efforts to improve sensitivity of detection, reliability, and reproducibility are warranted. A larger number of participants scanned by different MR scanners at different clinical sites are sometimes required to detect differences in BBB integrity between control and at-risk groups, which impose additional challenges. Here, we focus on these new challenges and propose some approaches to normalize and harmonize DCE data between different scanners. In brief, we recommend specific regions to be used for the tracer’s vascular input function and DCE data processing and how to find and correct negative Ktrans values that are physiologically impossible. We hope this information will prove helpful to new investigators wishing to study subtle BBB damage in neurovascular and neurodegenerative conditions and in the aging human brain.
- 25 April 2022
- Published by Springer Nature in GeroScience
- Vol. 44 (3) , 1339-1351
Imaging subtle leaks in the blood–brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions
Recent studies using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with gadolinium-based contrast agents (GBCA) have demonstrated subtle blood–brain barrier (BBB) leaks in the human brain during normal aging, in individuals with age-related cognitive dysfunction, genetic risk for Alzheimer’s disease (AD), mild cognitive impairment, early AD, cerebral small vessel disease (SVD), and other neurodegenerative disorders. In these neurological conditions, the BBB leaks, quantified by the unidirectional BBB GBCA tracer’s constant Ktrans maps, are typically orders of magnitude lower than in brain tumors, after stroke and/or during relapsing episodes of multiple sclerosis. This puts extra challenges for the DCE-MRI technique by pushing calculations towards its lower limits of detectability. In addition, presently, there are no standardized multivendor protocols or evidence of repeatability and reproducibility. Nevertheless, subtle BBB leaks may critically contribute to the pathophysiology of cognitive impairment and dementia associated with AD or SVD, and therefore, efforts to improve sensitivity of detection, reliability, and reproducibility are warranted. A larger number of participants scanned by different MR scanners at different clinical sites are sometimes required to detect differences in BBB integrity between control and at-risk groups, which impose additional challenges. Here, we focus on these new challenges and propose some approaches to normalize and harmonize DCE data between different scanners. In brief, we recommend specific regions to be used for the tracer’s vascular input function and DCE data processing and how to find and correct negative Ktrans values that are physiologically impossible. We hope this information will prove helpful to new investigators wishing to study subtle BBB damage in neurovascular and neurodegenerative conditions and in the aging human brain.
- Open Access
- 29 July 2021
- Published by Wiley in Brain and Behavior
- Vol. 11 (8)
Omega‐3 fatty acids are associated with blood–brain barrier integrity in a healthy aging population
In aging populations, omega‐3 polyunsaturated fatty acids (PUFAs) have been associated with better cognitive function, slower rates of cognitive decline, and lower risk of developing dementia. Animal studies have shown that diets rich in omega‐3 PUFAs reduce blood–brain barrier (BBB) disruption associated with aging, but this has yet to be observed in humans.Forty‐five healthy subjects (mean age, 76 years) were recruited and underwent cognitive assessment (verbal learning and memory, language, processing speed, executive function, and motor control) and measurement of PUFAs. Forty of the same subjects also underwent magnetic resonance imaging (MRI) to measure BBB integrity (Ktrans using dynamic contrast‐enhanced MRI).The long chain omega‐3 score (DHA+EPA) was negatively correlated with Ktrans values in the internal capsule, indicating higher omega‐3 levels were associated with greater BBB integrity in this region (r = –0.525, p = .004). Trends were observed for a positive correlation between the long chain omega‐3 score and both memory and language scores, but not with executive function, speed, or motor control. The omega‐6 score was not significantly correlated with any cognitive scores or Ktrans values.The significant correlations between long chain omega‐3 levels and BBB integrity provide a possible mechanism by which omega‐3 PUFAs are associated with brain health.
- 29 July 2021
- Published by Wiley in Brain and Behavior
- Vol. 11 (8)
Open AccessOmega‐3 fatty acids are associated with blood–brain barrier integrity in a healthy aging population
In aging populations, omega‐3 polyunsaturated fatty acids (PUFAs) have been associated with better cognitive function, slower rates of cognitive decline, and lower risk of developing dementia. Animal studies have shown that diets rich in omega‐3 PUFAs reduce blood–brain barrier (BBB) disruption associated with aging, but this has yet to be observed in humans.Forty‐five healthy subjects (mean age, 76 years) were recruited and underwent cognitive assessment (verbal learning and memory, language, processing speed, executive function, and motor control) and measurement of PUFAs. Forty of the same subjects also underwent magnetic resonance imaging (MRI) to measure BBB integrity (Ktrans using dynamic contrast‐enhanced MRI).The long chain omega‐3 score (DHA+EPA) was negatively correlated with Ktrans values in the internal capsule, indicating higher omega‐3 levels were associated with greater BBB integrity in this region (r = –0.525, p = .004). Trends were observed for a positive correlation between the long chain omega‐3 score and both memory and language scores, but not with executive function, speed, or motor control. The omega‐6 score was not significantly correlated with any cognitive scores or Ktrans values.The significant correlations between long chain omega‐3 levels and BBB integrity provide a possible mechanism by which omega‐3 PUFAs are associated with brain health.
- 14 June 2021
- Published by Springer Nature in Nature Aging
- Vol. 1 (6) , 506-520
APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β
Apolipoprotein E4 (APOE4), the main susceptibility gene for Alzheimer’s disease (AD), leads to vascular dysfunction, amyloid-β pathology, neurodegeneration and dementia. How these different pathologies contribute to advanced-stage AD remains unclear. Using aged APOE knock-in mice crossed with 5xFAD mice, we show that, compared to APOE3, APOE4 accelerates blood–brain barrier (BBB) breakdown, loss of cerebral blood flow, neuronal loss and behavioral deficits independently of amyloid-β. BBB breakdown was associated with activation of the cyclophilin A-matrix metalloproteinase-9 BBB-degrading pathway in pericytes. Suppression of this pathway improved BBB integrity and prevented further neuronal loss and behavioral deficits in APOE4;5FAD mice while having no effect on amyloid-β pathology. Thus, APOE4 accelerates advanced-stage BBB breakdown and neurodegeneration in Alzheimer’s mice via the cyclophilin A pathway in pericytes independently of amyloid-β, which has implication for the pathogenesis and treatment of vascular and neurodegenerative disorder in AD.
- 14 June 2021
- Published by Springer Nature in Nature Aging
- Vol. 1 (6) , 506-520
APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β
Apolipoprotein E4 (APOE4), the main susceptibility gene for Alzheimer’s disease (AD), leads to vascular dysfunction, amyloid-β pathology, neurodegeneration and dementia. How these different pathologies contribute to advanced-stage AD remains unclear. Using aged APOE knock-in mice crossed with 5xFAD mice, we show that, compared to APOE3, APOE4 accelerates blood–brain barrier (BBB) breakdown, loss of cerebral blood flow, neuronal loss and behavioral deficits independently of amyloid-β. BBB breakdown was associated with activation of the cyclophilin A-matrix metalloproteinase-9 BBB-degrading pathway in pericytes. Suppression of this pathway improved BBB integrity and prevented further neuronal loss and behavioral deficits in APOE4;5FAD mice while having no effect on amyloid-β pathology. Thus, APOE4 accelerates advanced-stage BBB breakdown and neurodegeneration in Alzheimer’s mice via the cyclophilin A pathway in pericytes independently of amyloid-β, which has implication for the pathogenesis and treatment of vascular and neurodegenerative disorder in AD.